TipRanks
Telix Pharmaceuticals Limited Unsponsored ADR (TLX)
NASDAQ:TLX
US Market
Want to see TLX full AI Analyst Report?

Telix Pharmaceuticals Limited Unsponsored ADR (TLX) Financial Statements

4 Followers

Telix Pharmaceuticals Limited Unsponsored ADR Financial Overview

Telix Pharmaceuticals Limited Unsponsored ADR's market cap is currently $4.01B. The company's EPS TTM is 0.1386; its P/E ratio is 116.21; Telix Pharmaceuticals Limited Unsponsored ADR is scheduled to report earnings on August 19, 2026, and the estimated EPS forecast is -0.02. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 1.21BAU$ 783.21MAU$ 502.55MAU$ 160.10MAU$ 7.60M
Gross ProfitAU$ 640.23MAU$ 509.68MAU$ 314.39MAU$ 94.93MAU$ 5.05M
Operating IncomeAU$ 26.64MAU$ 82.13MAU$ 15.84MAU$ -91.93MAU$ -81.25M
EBITDAAU$ 79.83MAU$ 98.23MAU$ 22.97MAU$ -92.84MAU$ -70.07M
Net IncomeAU$ -10.69MAU$ 49.92MAU$ 5.21MAU$ -104.08MAU$ -80.51M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 212.53MAU$ 710.35MAU$ 123.24MAU$ 116.33MAU$ 22.04M
Total AssetsAU$ 1.77BAU$ 1.52BAU$ 398.30MAU$ 255.35MAU$ 109.81M
Total DebtAU$ 699.77MAU$ 581.45MAU$ 17.45MAU$ 10.45MAU$ 2.54M
Net DebtAU$ 487.24MAU$ -128.90MAU$ -105.79MAU$ -105.88MAU$ -19.50M
Total LiabilitiesAU$ 1.15BAU$ 948.22MAU$ 249.39MAU$ 175.35MAU$ 106.17M
Stockholders' EquityAU$ 622.27MAU$ 568.21MAU$ 148.91MAU$ 80.01MAU$ 2.16M
Cash Flow
Free Cash FlowAU$ -82.80MAU$ 28.71MAU$ 14.21MAU$ -71.01MAU$ -60.67M
Operating Cash FlowAU$ -25.93MAU$ 43.03MAU$ 23.88MAU$ -63.97MAU$ -59.33M
Investing Cash FlowAU$ -428.79MAU$ -135.17MAU$ -25.49MAU$ -17.00MAU$ -2.73M
Financing Cash FlowAU$ -5.58MAU$ 638.92MAU$ 10.19MAU$ 174.96MAU$ 2.85M
Currency in AUD

Telix Pharmaceuticals Limited Unsponsored ADR Earnings and Revenue History

Telix Pharmaceuticals Limited Unsponsored ADR Debt to Assets

Telix Pharmaceuticals Limited Unsponsored ADR Cash Flow

Telix Pharmaceuticals Limited Unsponsored ADR Forecast EPS vs Actual EPS